{"id":"3e870a18-2ead-50f1-a2a5-629d4c2b348c","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-no-vegf-bfgf","predicate":"increases","statement":"Treatment significantly increased nitrate, VEGF and basic fibroblast growth factor levels and stabilised HIF-1alpha within one day, promoting blood vessel formation at 3 to 7 days and muscle healing at 5 to 7 days after contusion.","claim_class":"mechanistic","status":"source_derived_draft","evidence_grade":"ungraded","direction":"positive","is_public":true,"mechanism_event_id":"7c2ca192-3f75-56b7-847f-0eb945f99923","mechanism_event_label":"Within a day the growth signals rise; within a week there are new vessels and repaired muscle.","subject":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"object":{"id":"b306ec26-a6a3-5683-b338-6965500c689c","slug":"vegfa","display_name":"Vascular endothelial growth factor A","entity_type_key":"protein"},"evidence_count":1,"mechanism_event":{"id":"7c2ca192-3f75-56b7-847f-0eb945f99923","stable_key":"488ea171-36b8-5ef6-b5d3-98563980fdbf:hbot-no-vegf-bfgf-event","event_type":"biochemical_relationship","label":"Within a day the growth signals rise; within a week there are new vessels and repaired muscle.","description":"Treatment significantly increased nitrate, VEGF and basic fibroblast growth factor levels and stabilised HIF-1alpha within one day, promoting blood vessel formation at 3 to 7 days and muscle healing at 5 to 7 days after contusion.","status":"provisional","compartment":null,"participants":[{"entity":{"id":"063938ff-5685-5654-a7d9-d288b437c80c","slug":"fgf2","display_name":"Basic fibroblast growth factor / FGF2","entity_type_key":"protein"},"role":"induced_factor","stoichiometry":null,"state_label":"","sequence_order":0,"notes":""},{"entity":{"id":"f2a6b7ab-ad41-5ada-8895-41d6ce42f4e4","slug":"nitric-oxide","display_name":"NO","entity_type_key":"small_molecule"},"role":"upstream_mediator","stoichiometry":null,"state_label":"","sequence_order":1,"notes":""},{"entity":{"id":"22b3e241-94b0-55fd-a233-c63af92520d8","slug":"hif1a","display_name":"HIF-1 alpha","entity_type_key":"protein"},"role":"stabilised_factor","stoichiometry":null,"state_label":"","sequence_order":2,"notes":""},{"entity":{"id":"9dbb6cfa-50e1-5ff1-8b7e-6d747bf9ad03","slug":"angiogenesis","display_name":"Angiogenesis / new blood vessel formation","entity_type_key":"cellular_process"},"role":"downstream_process","stoichiometry":null,"state_label":"","sequence_order":3,"notes":""},{"entity":{"id":"581fa746-cb84-571b-87a0-4d461263f660","slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"},"role":"subject","stoichiometry":null,"state_label":"","sequence_order":4,"notes":""},{"entity":{"id":"b306ec26-a6a3-5683-b338-6965500c689c","slug":"vegfa","display_name":"Vascular endothelial growth factor A","entity_type_key":"protein"},"role":"target","stoichiometry":null,"state_label":"","sequence_order":5,"notes":""}]},"contexts":[{"dimension":"evidence_span","value_text":"{\"source_cache\": \"artifacts/hbot-research/32066777.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\", \"start_char\": 0, \"end_char\": 1357, \"text_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\"}","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"experimental_model","value_text":"Contused rat skeletal muscle with a reactive oxygen species scavenger and a nitric oxide synthase inhibitor","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"exposure","value_text":"2.5 ATA 100% oxygen for 120 minutes daily for 5 consecutive days","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"limitations","value_text":"Both inhibitors were given before treatment, which is what makes the requirement claim interpretable. The exposure is a therapy-like protocol, unlike the extreme-pressure studies recorded elsewhere here.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"nutrient_topic","value_text":"Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.","comparator":null,"unit":null,"notes":"","entity":{"slug":"hyperbaric-oxygen","display_name":"Hyperbaric oxygen therapy","entity_type_key":"drug"}},{"dimension":"organism","value_text":"Rat","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"plain_language","value_text":"Within a day the growth signals rise; within a week there are new vessels and repaired muscle.","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"primary_references","value_text":"[hbot-p32066777] VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/32066777/ DOI: 10.1038/s41598-020-59615-x","comparator":null,"unit":null,"notes":"","entity":null},{"dimension":"tissue_or_cell_type","value_text":"Skeletal muscle","comparator":null,"unit":null,"notes":"","entity":null}],"evidence":[{"id":"b44bead3-d841-5ef9-9202-bf38a04b58ef","evidence_kind":"source_excerpt","locator":"Lines 686-697","start_line":686,"end_line":697,"excerpt":"### hbot-no-vegf-bfgf\nTreatment significantly increased nitrate, VEGF and basic fibroblast growth factor levels and stabilised HIF-1alpha within one day, promoting blood vessel formation at 3 to 7 days and muscle healing at 5 to 7 days after contusion.\nCondition category: normal\nnutrient_topic: Hyperbaric oxygen research collection; topical membership is not evidence of a direct clinical effect, and a therapeutic exposure is not a dietary intake.\nplain_language: Within a day the growth signals rise; within a week there are new vessels and repaired muscle.\norganism: Rat\ntissue_or_cell_type: Skeletal muscle\nexperimental_model: Contused rat skeletal muscle with a reactive oxygen species scavenger and a nitric oxide synthase inhibitor\nlimitations: Both inhibitors were given before treatment, which is what makes the requirement claim interpretable. The exposure is a therapy-like protocol, unlike the extreme-pressure studies recorded elsewhere here.\nexposure: 2.5 ATA 100% oxygen for 120 minutes daily for 5 consecutive days\nevidence_span: {\"source_cache\": \"artifacts/hbot-research/32066777.abstract.txt\", \"locator\": \"Indexed abstract; zero-based, end-exclusive Unicode character offsets\", \"file_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\", \"start_char\": 0, \"end_char\": 1357, \"text_sha256\": \"f8915aa50d5b22722e66d20eb0542c6bb03b76a3182d37215a53bc9238ac697d\"}\n[hbot-p32066777] VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/32066777/ DOI: 10.1038/s41598-020-59615-x","model_system":"Contused rat skeletal muscle with a reactive oxygen species scavenger and a nitric oxide synthase inhibitor","directness":"author_interpretation","verification_status":"source_derived_draft","notes":"Exact curation-document quotation, not publisher quotation. Study references: [hbot-p32066777] VEGF and bFGF induction by nitric oxide is associated with hyperbaric oxygen-induced angiogenesis and muscle regeneration. (2020). https://pubmed.ncbi.nlm.nih.gov/32066777/ DOI: 10.1038/s41598-020-59615-x","relationship":"supports","weight":1.0,"link_notes":"","source":{"id":"dbf39b48-c95e-5291-b404-349ffbc4488f","stable_key":"import-488ea171-36b8-5ef6-b5d3-98563980fdbf","title":"Hyperbaric oxygen: the exposure, its reactive species, the signals they carry, and the nutrient-dependent enzymes that handle them (2026-09-19)","document_type":"imported_text","citation_label":"AI-assisted literature curation; primary study URLs and scope retained in the document and extraction. Not publisher full text.","file_path":"","sha256":"fb2443321804010d82c6b96ab61cc51b4b6628ddbb15751cb0e90b491606e79c","revision_id":"bb699ea5-b492-5728-b22c-48f0842a8ac9","review_status":"unverified_draft","notes":""}}],"relations":[],"conflicts":[],"corrections":[],"research":null}